NHS Trial: AI Software Promises Faster Prostate Cancer Diagnosis
NHS launches Trial for Same-Day Prostate Cancer Diagnosis Using AI
London,UK – In a move hailed as perhaps “game changing,” the National Health Service (NHS) is trialling artificial intelligence (AI) software to offer same-day prostate cancer diagnosis to patients following urgent GP referral. The initiative,launched at University college London Hospital (UCLH),aims to drastically reduce wait times and alleviate anxiety for men facing potential cancer diagnoses.
Currently, best-practice guidelines recommend an MRI and biopsy within a week of urgent referral, but capacity constraints frequently enough lead to longer delays.The AI software, called Pi, developed by Lucida Medical, is being lauded for its speed and efficiency in analyzing scans. “MRI in the morning, biopsy in the afternoon,” Dr. Oliver Hulson of Lucida Medical wrote on the developerS website, illustrating the potential impact of the technology.
Fourteen other NHS trusts are also participating in trials of the Pi software, though they are not yet offering same-day biopsy services.
The rollout comes as prostate cancer diagnoses continue to rise. According to the National Prostate Cancer Audit, 58,218 men were diagnosed with prostate cancer in England in 2024 – an increase of over 5,000 cases compared to the previous year. Unlike breast cancer, there is currently no national screening program for prostate cancer in the UK.
health Secretary Wes Streeting stated the trial would cut “needlessly distressing” wait times and improve patient outcomes. “By harnessing the power of technology we are revolutionising our NHS,” he said.
Professor Peter Johnson, national clinical director for cancer at the NHS, expressed hope that the technology could ”help save men weeks of worry and uncertainty.” Amy Rylance, assistant director of health improvement at Prostate Cancer UK, added that Pi could reduce ”prolonged anxiety and the bother of hospital trips, while also increasing capacity for our hard-working NHS workforce.”
The trial’s announcement precedes the release of the government’s National Cancer Plan, expected later this year.